Back to Search Start Over

Paxlovid for nonhospitalized patients with COVID‐19.

Authors :
Johari, Fatima
Verma, Rajesh
Source :
Academic Emergency Medicine; Jun2024, Vol. 31 Issue 6, p621-623, 3p
Publication Year :
2024

Abstract

The article focuses on Paxlovid's effectiveness in nonhospitalized COVID-19 patients, highlighting uncertainties regarding its impact on mortality and hospitalization. It discusses concerns over virologic rebound and adverse effects like dysgeusia and gastrointestinal symptoms. It also discusses variations in trial populations and methodological rigor, underscoring the need for further conclusive data in assessing its overall benefit-risk profile.

Subjects

Subjects :
THERAPEUTIC use of protease inhibitors
COMBINATION drug therapy
RISK assessment
COMMUNICABLE diseases
ORAL drug administration
SEVERITY of illness index
TREATMENT effectiveness
DRUG approval
PROTEASE inhibitors
DRUG efficacy
CYTOCHROME P-450
RITONAVIR
CLINICS
COVID-19
DISEASE progression

Details

Language :
English
ISSN :
10696563
Volume :
31
Issue :
6
Database :
Complementary Index
Journal :
Academic Emergency Medicine
Publication Type :
Academic Journal
Accession number :
177819307
Full Text :
https://doi.org/10.1111/acem.14896
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details